These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8982041)

  • 1. An improved animal model for studying desferrioxamine.
    Steward A; Williamson I; Madigan T; Bretnall A; Hassan IF
    Br J Haematol; 1996 Dec; 95(4):654-9. PubMed ID: 8982041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-encapsulated desferrioxamine in experimental iron overload.
    Lau EH; Cerny EA; Rahman YE
    Br J Haematol; 1981 Apr; 47(4):505-18. PubMed ID: 7213574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of iron chelation by desferrioxamine entrapped in red blood cell ghosts.
    Green R; Miller J; Crosby W
    Blood; 1981 May; 57(5):866-72. PubMed ID: 7214016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilisation of iron from peritoneal rat macrophages by desferrioxamine.
    Kleber EE; Torrance JD; Bothwell TH; Simon MO; Charlton RW
    Scand J Haematol; 1981 Sep; 27(3):209-18. PubMed ID: 7313547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelation of transferrin iron by desferrioxamine in K562 cells. The partition of iron between ferrioxamine and ferritin.
    Roberts S; Bomford A
    Biochem J; 1988 Sep; 254(3):869-75. PubMed ID: 3196300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte iron kinetics in the rat explored with an iron chelator.
    Pippard MJ; Johnson DK; Finch CA
    Br J Haematol; 1982 Oct; 52(2):211-24. PubMed ID: 7126464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo iron mobilisation evaluation of hydroxypyridinones in 59Fe-ferritin-loaded rat model.
    Liu ZD; Lu SL; Hider RC
    Biochem Pharmacol; 1999 Mar; 57(5):559-66. PubMed ID: 9952320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron mobilization from cultured hepatocytes: effect of desferrioxamine B.
    Octave JN; Schneider YJ; Crichton RR; Trouet A
    Biochem Pharmacol; 1983 Nov; 32(22):3413-8. PubMed ID: 6651865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects.
    Summers MR; Jacobs A; Tudway D; Perera P; Ricketts C
    Br J Haematol; 1979 Aug; 42(4):547-55. PubMed ID: 476006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced iron removal from liver parenchymal cells in experimental iron overload: liposome encapsulation of HBED and phenobarbital administration.
    Rahman YE; Cerny EA; Lau EH; Carnes BA
    Blood; 1983 Jul; 62(1):209-13. PubMed ID: 6407548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an intravenous desferrioxamine mesylate treatment protocol for swine: monitoring of desferrioxamine and metabolites by high-performance liquid chromatography.
    Fisher EA; McLachlan DR; Kruck TP; Mustard RA
    Pharmacology; 1990; 41(5):263-71. PubMed ID: 2092330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of interferon and desferrioxamine on serum ferritin and hepatic iron concentrations in chronic hepatitis B.
    Bayraktar Y; Saglam F; Temizer A; Uzunalimodlu B; van Thiel DH
    Hepatogastroenterology; 1998; 45(24):2322-7. PubMed ID: 9951916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fate of intravenously injected tissue ferritin in pregnant guinea-pigs.
    Lamparelli RD; Friedman BM; MacPhail AP; Bothwell TH; Phillips JI; Baynes RD
    Br J Haematol; 1989 May; 72(1):100-5. PubMed ID: 2736234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells.
    Hershko C; Cook JD; Finch DA
    J Lab Clin Med; 1973 Jun; 81(6):876-86. PubMed ID: 4196982
    [No Abstract]   [Full Text] [Related]  

  • 17. Liposome entrapped desferrioxamine and iron transporting ionophores: a new approach to iron chelation therapy.
    Young SP; Baker E; Huehns ER
    Br J Haematol; 1979 Mar; 41(3):357-63. PubMed ID: 427040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic analysis of desferrioxamine. Pharmacokinetic and metabolic studies.
    Kruck TP; Teichert-Kuliszewska K; Fisher E; Kalow W; McLachlan DR
    J Chromatogr; 1988 Dec; 433():207-16. PubMed ID: 3235548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
    Baker E; Page M; Torrance J; Grady R
    Clin Physiol Biochem; 1985; 3(6):277-88. PubMed ID: 4075694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of iron from an oral dose into the ferritin of the duodenal mucosa and the liver of normal and iron-deficient rats.
    Ehtechami C; Elsenhans B; Forth W
    J Nutr; 1989 Feb; 119(2):202-10. PubMed ID: 2918392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.